Latest filing published 29 Jun 2023 for Neola Medical AB (tidigare GPX Medical), €9,186.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mattias Lundin: trading record in brief
Mattias Lundin appears in our data through filings on Neola Medical AB (tidigare GPX Medical) shares, published by Finansinspektionen. In total, 4 filings cover trades dated from 6 October 2022 to 27 June 2023.
Every open-market trade on record is a purchase: 1 purchase, and no sale. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 29 June 2023 came the latest disclosure, a transaction for €9,186 in Neola Medical AB (tidigare GPX Medical). The last purchase on record was published on 7 October 2022, which is 1,493 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Mattias Lundin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300,000 shares@ SEK 0.3660.9% of flowTeckningsoptionFI:csv-18be2f41b88afc24a36c
- 50,000 shares@ SEK 1.3039.1% of flowBTA (betald tecknad aktie)ISIN SE0018689044FI:csv-34b333d51076edd30462
- 25,000 shares0Teckningsrätt/UniträttISIN SE0018689044FI:csv-d813b0616189e47c5b10
- 25,000 shares0Teckningsrätt/UniträttISIN SE0018689044FI:csv-f9ca0437ec42e5873574Canonical exit: 4 Jan 2023 (T+90)
4 of 4 declarations